Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma

An 82-year-old woman presented with a 9-month history of multiple, well-defined skin lesions on her neck and upper chest, progressively increasing in size. Histological examination of a skin biopsy showed a regular epidermis. In the dermis, granulomatous changes with central necrobiosis were found which extended focally into the subcutaneous fat. The necrobiotic areas were surrounded by Touton cells and foreign-body giant cells. Laboratory analysis revealed leucopenia. Serum electrophoresis and immunofixation disclosed the presence of an IgG-λ paraprotein. Bone marrow aspiration cytology showed 20% plasmatic cells. The skeletal X-ray revealed frontal and occipital osteolytic skull lesions as well as pubic osteolysis. Urinalysis was unremarkable without proteinuria. Based on the clinical, laboratory, and histological findings, necrobiotic xanthogranuloma in association with multiple myeloma was diagnosed. The patient was treated with bortezomib combined with oral dexamethasone. Follow-up at week 13 revealed the complete disappearance of the IgG paraproteinemia. However, the skin lesions remained unchanged. Therefore, bortezomib treatment was discontinued, and systemic corticosteroids were continued at a higher dosage. After the steroid treatment, the lesions markedly flattened.

[1]  O. Rodriguez,et al.  Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine). , 2016, JAMA dermatology.

[2]  Min Yang,et al.  Long-term disease control in a refractory multiple myeloma patient treated with bortezomib mono-therapy: a case report and review of literature. , 2015, International journal of clinical and experimental medicine.

[3]  V. Sharma,et al.  Necrobiotic xanthogranuloma with multiple myeloma , 2015, Clinical and experimental dermatology.

[4]  E. Boh,et al.  Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin , 2014, Dermatologic therapy.

[5]  E. Ryan,et al.  Necrobiotic xanthogranuloma: Response to chlorambucil , 2012, The Australasian journal of dermatology.

[6]  É. Oksenhendler,et al.  Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. , 2011, Blood.

[7]  D. Mehregan,et al.  Necrobiotic xanthogranuloma , 2009, International journal of dermatology.

[8]  M. Landthaler,et al.  Cyclophosphamide–dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement , 2005, The British journal of dermatology.

[9]  P. Holt,et al.  Recalcitrant necrobiotic xanthogranuloma responding to pulsed high‐dose oral dexamethasone plus maintenance therapy with oral prednisolone , 2001, The British journal of dermatology.

[10]  S. Yamashita,et al.  Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia--a possible pathogenesis of necrobiotic xanthogranuloma. , 1999, Atherosclerosis.

[11]  J. Verbov,et al.  Necrobiotic xanthogranuloma with paraproteinaemia , 1985, The British journal of dermatology.

[12]  A. Rashidi,et al.  Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation. , 2012, Cutis.